Redeye comments on Xspray following an undramatic Q1 report.
Redeye updates on Invisio following weaker than expected Q1-results.
Orders +4%, sales -9%, adj. EBITA -22% vs. our estimates EBITA miss driven by 3 high-volume delivery...
Redeye updates its estimates and valuation following Cheffelo’s Q1 2025 report.
Redeye provides an in-depth take on AroCell’s Q1 report.
Suominen's Q1 was fairly in line with Vara Research consensus, while the company also announced a la...
6% organic sales decline y-o-y Enmac shows progress with good order intake Adj.
Surprisingly high costs, but solid top-line and customer intake We cut '25e EBITA by 7%, but raise '...
Cost reduction initiatives in DE and NL short-term Focus on margin improvement journey and selective...
Report out 14 May at 07:45 CEST Pome sale the largest Q1 contributor, Stor-Skälsjön completed Q1e EB...
Redeye comments on Avensia’s Q1 report, beating our expectations significantly on both sales and EBI...
Enersense won a contract with Fingrid to build the 400/110 kV transformer substation and related pow...
JonDeTechs första kvartal 2025 präglades av sju nya aktiva kundprojekt där det tidigare aviserade pr...
Sales trough reached, return to EBIT growth in Q3e '25e-'27e EBIT down 29-13% on FX and system sales...
Suominen Q1 comparable EBITDA of EUR 4.1m came fairly in line with Vara Research consensus expectati...
